Ventus Therapeutics

Channel: Ventus Therapeutics

↧

Xavier Valencia, M.D.

March 6, 2024, 6:40 am

Xavier is the Head of Clinical Development of Ventus Therapeutics. He brings to Ventus more than 25 years of industry and academic experience in immunology and autoimmunity. Prior to Ventus, Xavier...

View Article

Xavier Valencia, M.D.

March 6, 2024, 6:56 am

Xavier Valencia est directeur du Développement clinique chez Ventus Thérapeutique. Il apporte à Ventus plus de 25 ans d’expérience en industrie et en milieu universitaire dans les domaines de...

View Article

Jason Burch, Ph.D.

April 2, 2024, 6:26 am

Jason is the Head of Platform Technologies at Ventus Therapeutics. Prior to joining Ventus, Jason was Director, Head of Chemistry at Inception Sciences, Inc., a drug discovery engine co-founded with...

View Article

Jason Burch, Ph.D.

April 2, 2024, 6:28 am

Le Dr Burch est directeur des plateformes technologues chez Ventus Thérapeutique. Avant de se joindre à Ventus, il a été directeur de la chimie chez Inception Sciences Inc., une entreprise de...

View Article

Principal Investigator, Translational Science (Biomarker Strategy)

April 2, 2024, 11:34 am

Ventus TherapeuticsWaltham or Montreal The post Principal Investigator, Translational Science (Biomarker Strategy) appeared first on Ventus Therapeutics.

View Article

Senior Scientist, Machine Learning

April 2, 2024, 11:35 am

Ventus TherapeuticsWaltham or Montreal (Hybrid) The post Senior Scientist, Machine Learning appeared first on Ventus Therapeutics.

View Article

Image may be NSFW.
Clik here to view.

Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor...

April 8, 2024, 5:28 am

WALTHAM, Mass. & MONTREAL — April 8, 2024 — (BUSINESS WIRE) — Ventus Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing its deep protein science expertise and proprietary...

View Article

Ventus Thérapeutique présentera à la conférence Bloom Burton & Co Healthcare...

April 8, 2024, 5:28 am

WALTHAM, Mass. et MONTRÉAL – 8 avril 2024 – (BUSINESS WIRE) – Ventus Thérapeutique inc., une société biopharmaceutique de stade clinique qui fait appel à son expérience approfondie en science des...

View Article

Image may be NSFW.
Clik here to view.

Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02,...

April 17, 2024, 5:32 am

VENT-02 demonstrated robust pharmacodynamic modulation, a broad therapeutic index, and potential for once-daily dosing VENT-02 provided full target coverage with a single dose No dose-limiting...

View Article

Ventus Thérapeutique annonce les résultats de son essai clinique de phase I...

April 17, 2024, 6:05 pm

Les résultats ont montré que le VENT-02 présentait un profil robuste de modulation pharmacodynamique, un index thérapeutique étendu et la possibilité d’administrer le médicament une fois par jour Une...

View Article

Image may be NSFW.
Clik here to view.

Ventus Therapeutics Announces First Participant Dosed in Clinical Study with...

May 3, 2024, 5:04 am

WALTHAM, Mass. & MONTREAL — May 3, 2024 — (BUSINESS WIRE) — Ventus Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing its proprietary structural biology and computational...

View Article

Ventus Thérapeutique annonce l’administration d’un inhibiteur de NLRP3 au...

May 3, 2024, 5:05 am

WALTHAM, Mass. et MONTRÉAL – 3 mai 2024 – (BUSINESS WIRE) – Ventus Thérapeutique inc., une société biopharmaceutique de stade clinique qui utilise ReSOLVETM, sa plateforme exclusive de biologie...

View Article

Xavier Valencia, M.D.

March 6, 2024, 6:56 am

View Article

Associate Director, Clinical Operations

June 10, 2024, 10:05 am

Ventus TherapeuticsWaltham (Hybrid) The post Associate Director, Clinical Operations appeared first on Ventus Therapeutics.

View Article

Director, Medical Affairs

June 10, 2024, 10:06 am

Ventus TherapeuticsWaltham or Montreal (Remote) The post Director, Medical Affairs appeared first on Ventus Therapeutics.

View Article

Ventus Thérapeutique accroît sa présence à Montréal, au Canada, avec...

July 16, 2024, 5:00 am

Les nouvelles installations ultramodernes de 24 000 pieds carrés permettront à Ventus d’être en meilleure posture pour alimenter sa gamme de produits en développement, grâce à la perspective de faire...

View Article

Image may be NSFW.
Clik here to view.

Ventus Therapeutics Significantly Expands its Presence in Montreal, Canada...

July 16, 2024, 5:00 am

New 24,000-square-foot state-of-the-art facility will facilitate the build-out of Ventus’ pipeline, enabled by the vision to develop its ReSOLVE platform into a disruptive drug discovery platform...

View Article